Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Facebook Stock Stands to Benefit as the World Embraces Its Apps

By Josh Enomoto, InvestorPlace Contributor

If you think that social media alpha dog Facebook stock can’t learn new tricks, think again. It’s about to roil the competition in the increasingly relevant international space.

What’s Really Driving Demand for Tesla Stock?

By Josh Enomoto, InvestorPlace Contributor

TSLA stock seems like a strong buy thanks to an even stronger Q4 vehicle deliveries report. However, the driving force behind this demand may make investors think twice.

7 Stocks to Sell to Start the New Year Fresh

By Josh Enomoto, InvestorPlace Contributor

Although talking about stocks to sell typically elicits anger and negative emotions, this list is all about protecting your interests.

3 Reasons Why ROKU Can Still Win in 2020

By Josh Enomoto, InvestorPlace Contributor

Roku stock was an absolute winner in 2019. However, that won’t stop shares from ticking higher in 2020 thanks to the robust streaming market.

How Many Lives Does Nokia Have Remaining?

By Josh Enomoto, InvestorPlace Contributor

In the best of circumstances, Nokia shares represented a speculative bet. But in stumbling out of the gates in the ultra-competitive 5G race, the company lost much credibility.

What Hexo Stock Needs Is Some Old-Fashioned Reaganomics

By Josh Enomoto, InvestorPlace Contributor

Last year was a year of reckoning for Hexo stock and the broader cannabis market. However, most of the pain may have resulted from unnecessary government inefficiencies.

Amarin Risks Getting Exposed as a Paper Tiger

By Josh Enomoto, InvestorPlace Contributor

Pharmaceutical companies are always difficult investment propositions, and Amarin shares proved why with its perhaps unjustifiably hyped drug Vascepa.

Don’t Expose Yourself to NAKD Stock

By Josh Enomoto, InvestorPlace Contributor

Contrarians love discounts. However, the ridiculously bad volatility that NAKD stock incurred should be avoided because it’s bad for a reason.

The 7 Best Long-Term Stocks to Buy for 2020 and Beyond

By Josh Enomoto, InvestorPlace Contributor

Even the best long-term stocks require some patience, but their viable growth industries make them the best stocks for 2019 and beyond!

Why 5G – Not Memory Pricing – is Key Driver for Micron Stock

By Josh Enomoto, InvestorPlace Contributor

According to conventional wisdom, memory chip pricing will affect the trajectory of Micron stock. However, with the 5G rollout, the underlying tech firm has more tailwinds than risk factors.

Load More